chr1-151666010-T-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001330723.2(SNX27):​c.984T>C​(p.Phe328Phe) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000834 in 1,609,738 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 6 hom. )

Consequence

SNX27
NM_001330723.2 splice_region, synonymous

Scores

2
Splicing: ADA: 0.001161
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.37

Publications

2 publications found
Variant links:
Genes affected
SNX27 (HGNC:20073): (sorting nexin 27) This gene encodes a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). A highly similar protein in mouse is responsible for the specific recruitment of an isoform of serotonin 5-hydroxytryptamine 4 receptor into early endosomes, suggesting the analogous role for the human protein. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 1-151666010-T-C is Benign according to our data. Variant chr1-151666010-T-C is described in ClinVar as Benign. ClinVar VariationId is 462822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.37 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00412 (628/152370) while in subpopulation AFR AF = 0.0134 (559/41592). AF 95% confidence interval is 0.0125. There are 2 homozygotes in GnomAd4. There are 283 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 628 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330723.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNX27
NM_001330723.2
MANE Select
c.984T>Cp.Phe328Phe
splice_region synonymous
Exon 6 of 12NP_001317652.1
SNX27
NM_030918.6
c.984T>Cp.Phe328Phe
splice_region synonymous
Exon 6 of 12NP_112180.4
SNX27
NM_001437601.1
c.681T>Cp.Phe227Phe
splice_region synonymous
Exon 5 of 11NP_001424530.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNX27
ENST00000458013.7
TSL:5 MANE Select
c.984T>Cp.Phe328Phe
splice_region synonymous
Exon 6 of 12ENSP00000400333.2
SNX27
ENST00000368843.8
TSL:1
c.984T>Cp.Phe328Phe
splice_region synonymous
Exon 6 of 12ENSP00000357836.3
SNX27
ENST00000368838.2
TSL:1
c.579T>Cp.Phe193Phe
splice_region synonymous
Exon 5 of 10ENSP00000357831.2

Frequencies

GnomAD3 genomes
AF:
0.00411
AC:
626
AN:
152252
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0134
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00119
AC:
298
AN:
249520
AF XY:
0.000867
show subpopulations
Gnomad AFR exome
AF:
0.0133
Gnomad AMR exome
AF:
0.000444
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000706
Gnomad OTH exome
AF:
0.000990
GnomAD4 exome
AF:
0.000490
AC:
714
AN:
1457368
Hom.:
6
Cov.:
29
AF XY:
0.000466
AC XY:
338
AN XY:
725004
show subpopulations
African (AFR)
AF:
0.0131
AC:
439
AN:
33390
American (AMR)
AF:
0.000360
AC:
16
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.00579
AC:
151
AN:
26060
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39608
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85758
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53302
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000361
AC:
40
AN:
1108848
Other (OTH)
AF:
0.00106
AC:
64
AN:
60176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00412
AC:
628
AN:
152370
Hom.:
2
Cov.:
32
AF XY:
0.00380
AC XY:
283
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0134
AC:
559
AN:
41592
American (AMR)
AF:
0.00118
AC:
18
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68040
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00173
Hom.:
1
Bravo
AF:
0.00420
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

SNX27-related disorder Benign:1
Apr 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Severe myoclonic epilepsy in infancy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
12
DANN
Benign
0.87
PhyloP100
1.4
Mutation Taster
=40/60
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0012
dbscSNV1_RF
Benign
0.020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150091333; hg19: chr1-151638486; API